CME vs. NVO
CME (CME Group Inc.) and NVO (Novo Nordisk A/S) are both stocks. CME operates in Financial Data & Stock Exchanges (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, CME returned 15.38%/yr vs 7.56%/yr for NVO. At a 0.21 correlation, their price movements are largely independent.
Performance
CME vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CME achieves a 1.58% return, which is significantly higher than NVO's -10.74% return. Over the past 10 years, CME has outperformed NVO with an annualized return of 15.38%, while NVO has yielded a comparatively lower 7.56% annualized return.
CME
- 1D
- 2.80%
- 1M
- -8.82%
- YTD
- 1.58%
- 6M
- 1.41%
- 1Y
- 3.34%
- 3Y*
- 19.92%
- 5Y*
- 9.17%
- 10Y*
- 15.38%
NVO
- 1D
- -0.18%
- 1M
- -6.80%
- YTD
- -10.74%
- 6M
- -9.50%
- 1Y
- -43.34%
- 3Y*
- -15.59%
- 5Y*
- 2.92%
- 10Y*
- 7.56%
CME vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CME CME Group Inc. | 1.58% | 19.83% | 15.41% | 31.32% | -22.89% | 29.47% | -6.34% | 9.67% | 32.15% | 32.35% |
NVO Novo Nordisk A/S | -10.74% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between CME and NVO is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Dec 6, 2002 | 0.21 |
The correlation between CME and NVO shifts across timeframes, from -0.02 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CME:
$97.90B
NVO:
$195.21B
CME:
$11.75
NVO:
DKK 27.42
CME:
22.94
NVO:
10.34
CME:
2.00
NVO:
0.44
CME:
14.40
NVO:
3.85
CME:
3.68
NVO:
6.21
CME:
$6.76B
NVO:
DKK 327.80B
CME:
$5.84B
NVO:
DKK 268.30B
CME:
$5.69B
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CME vs. NVO — Risk / Return Rank
CME
NVO
CME vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CME | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.00 | ||
| Sortino ratioReturn per unit of downside risk | +1.40 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 0.85 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 0.16 | -0.80 | +0.96 |
| Martin ratioReturn relative to average drawdown | 0.50 | -1.18 | +1.68 |
Loading charts...
Drawdowns
CME vs. NVO - Drawdown Comparison
The maximum CME drawdown since its inception was -77.50%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for CME and NVO.
Loading charts...
Drawdown Indicators
| CME | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.50% | -74.70% | -2.80% |
Max Drawdown (1Y)Largest decline over 1 year | -21.42% | -54.34% | +32.92% |
Max Drawdown (3Y)Largest decline over 3 years | -21.42% | -74.70% | +53.28% |
Max Drawdown (5Y)Largest decline over 5 years | -31.74% | -74.70% | +42.96% |
Max Drawdown (10Y)Largest decline over 10 years | -37.36% | -74.70% | +37.34% |
Current DrawdownCurrent decline from peak | -15.03% | -68.11% | +53.08% |
Average DrawdownAverage peak-to-trough decline | -20.68% | -17.79% | -2.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.70% | 37.62% | -30.92% |
Volatility
CME vs. NVO - Volatility Comparison
CME Group Inc. (CME) and Novo Nordisk A/S (NVO) have volatilities of 10.45% and 10.68%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CME | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.45% | 10.68% | -0.23% |
Volatility (6M)Calculated over the trailing 6-month period | 17.44% | 38.04% | -20.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.74% | 51.88% | -31.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.15% | 38.33% | -18.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.93% | 32.56% | -8.63% |
Dividends
CME vs. NVO - Dividend Comparison
CME's dividend yield for the trailing twelve months is around 4.17%, more than NVO's 4.11% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CME CME Group Inc. | 4.17% | 1.83% | 4.48% | 4.58% | 5.05% | 3.00% | 3.24% | 2.74% | 2.42% | 4.20% | 4.90% | 5.41% |
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
CME vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between CME Group Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CME vs. NVO - Profitability Comparison
CME - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
CME - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
CME - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
CME and NVO have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (10.68%) compared to CME (10.45%). In terms of maximum drawdown, CME dropped -77.50% vs NVO's -74.70%.
CME currently has the higher Sharpe Ratio (0.16 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CME and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer